Advertisement

Reactions Weekly

, Volume 1719, Issue 1, pp 220–220 | Cite as

Sorafenib

Skin toxicity: 3 case reports
Case report
  • 15 Downloads

Reference

  1. Raciborska A, et al. Sorafenib in patients with progressed and refractory bone tumors. Medical Oncology 35: 126, No. 10, 16 Aug 2018. Available from: URL: http://doi.org/10.1007/s12032-018-1180-x - Poland

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations